Alzheimer's Disease Trial, Recruiting (NCT07227961)

Alzheimer's Disease Trial, Recruiting NCT07227961 Sponsor: University of Calgary Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07227961 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with bone sarcoma, soft tissue sarcoma, or a giant cell tumor of the bone
Your tumor is located in the pelvis, arm, or leg
Your cancer may be either a new diagnosis or one that has come back after previous treatment
You are having surgery to remove the tumor, which may include surgery that saves the limb or an amputation
You own an iPhone or Android smartphone
You speak English

Who may not be able to join:

Your cancer has spread (metastasized) from another part of the body to the bone
You have been diagnosed with a specific type of fatty tumor (atypical lipomatous tumor) or a specific skin tumor (dermatofibrosarcoma protuberans)
You are currently pregnant or are planning to become pregnant within the next 6 months
You are unwilling or unable to attend follow-up appointments as required by the trial
You have difficulties with thinking, understanding, or communicating that would make it hard to complete questionnaires (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07227961

Sponsor: University of Calgary

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

More information: https://clinicaltrials.gov/study/NCT07227961

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You have been diagnosed with bone sarcoma, soft tissue sarcoma, or a giant cell tumor of the bone
Your tumor is located in the pelvis, arm, or leg
Your cancer may be either a new diagnosis or one that has come back after previous treatment
You are having surgery to remove the tumor, which may include surgery that saves the limb or an amputation
You own an iPhone or Android smartphone
You speak English

Who may not be able to join:

Your cancer has spread (metastasized) from another part of the body to the bone
You have been diagnosed with a specific type of fatty tumor (atypical lipomatous tumor) or a specific skin tumor (dermatofibrosarcoma protuberans)
You are currently pregnant or are planning to become pregnant within the next 6 months
You are unwilling or unable to attend follow-up appointments as required by the trial
You have difficulties with thinking, understanding, or communicating that would make it hard to complete questionnaires (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Calgary

Registry

ClinicalTrials.gov

Start date

1 July 2025

Est. completion

30 June 2030

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

Step count; Distance travelled; Flights of stairs climbed; Gait asymmetry; Distinct activity periods; Total time active; PROMIS Global Health; PROMIS Self Efficacy; PROMIS Pain Interference; PROMIS Physical Function; PROMIS Upper Extremity Function; Toronto Extremity Salvage Score Lower Extremity; Toronto Extremity Salvage Score Upper Extremity; Maximal oxygen consumption (VO2 max); Heart rate; Heart rate variability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov